HomePharma & BiotechCROProgressing the Metabolic Charge

Progressing the Metabolic Charge

The human nature can be defined through a lot of different adjectives, but when push comes to shove, nothing would do a better job than our ability to grow on a consistent basis. This progressive approach, on our part, has already got the world to hit upon some huge milestones, with technology appearing as a major member of the stated group. The reason why technology enjoys such an esteemed stature among people is, by and large, predicated upon its skill-set, which guided us towards a reality that nobody could have ever imagined otherwise. Nevertheless, if we look up close for a second, it will become clear how the whole runner was also very much inspired from the way we applied those skills across a real world environment. The latter component was, in fact, what gave the creation a spectrum-wide presence, and consequentially, kickstarted a full-blown tech revolution. Of course, this revolution then went to scale up the human experience through some outright unique avenues, but even after achieving such a monumental feat, technology will somehow continue to produce the right goods. The same has grown to become a lot more evident in recent times, and assuming one new healthcare-themed development shakes out just like we envision, it will only make that trend bigger and better moving forward.

Lindus Health, an “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has officially announced the launch of an all-in-one package containing contract research organization (CRO) services, site services and clinical trial technology to support research within the metabolic space. Talk about the stated package on a slightly deeper level, it begins from end-to-end trial management and execution services, services that cover the entire study delivery value chain, right from designing effective study protocols and recruitment strategies tailored as per the patient populations, to data collection, management, and final delivery. Next up, we must get into all the knowledge that Lindus Health’s experts bring here in terms of metabolic market segment and regulatory affairs. You see, thanks to its experience in preparing ethics submissions across numerous countries, Lindus Health helps you big time when the agenda is to stay updated on the ever-changing regulatory landscapes especially in metabolic health. Then, there is the prospect of patient recruitment that makes it possible for metabolic sponsors to achieve enrollment goals on-time by leveraging a variety of different recruitment strategies. Complimenting the same is a an extensive network of over 30 million electronic health records (EHRs) and a dedicated digital marketing team built for multi-channel recruitment initiatives, two factors that should let you target a versatile set of patient populations to participate in metabolic studies. Moving on to the package’s end-to-end eClinical “Citrus” platform, it is basically Lindus Health’s proprietary home-grown Clinical Trial Management S(CTMS) and Electronic Data Capture (EDC) software which can unite all the essential technologies to run clinical trials under one roof, therefore mitigating the risks historically associated with fragmentation of data across multiple software products. Rounding up the highlights are these site management services that refers to Lindus Health’s in-house site operations team and how it has conducted single and multi-site studies, as well as traditional to fully virtual and hybrid clinical trial models within metabolic research. It also touches on the company’s on-site team, which is conceived on the back of extensive resumes in metabolic study execution, covering roles across PIs, CRCs, and more.

“With the prevalence of metabolic disease growing on a global scale, and the massive uptick in research with the advent of GLP-1s, we want to use our unique expertise and capabilities to accelerate approvals of these essential therapies,” said Emma Ogburn, VP of Clinical Operations at Lindus Health. “Our All-in-One Metabolic CRO offering is designed to streamline study activities at every stage of research. We’re thrilled to be applying our extensive metabolic expertise to offer an all-in-one approach including study execution, site management, and technology services to sponsors in this area.”

The whole development follows up fittingly on Lindus Health’s already impressive track record in metabolic health. To give you concrete numbers, the company has completed, so far, more than 18 end-to-end studies, with over 1,600 patients enrolled across US and Europe in the context of treating indications such as obesity, diabetes and more. This it has been able to achieve largely through a bespoke “All-in-One Metabolic CRO” offering. The stated offering, in simple terms, combines the expertise of a seasoned full service CRO and internal site/PI expertise with a distinctive technology driven approach on its proprietary Citrus™ platform, thus enabling metabolic sponsors to run faster, more patient-centric clinical trials.

Having referred to the company’s work in and around metabolic health, we also need to acknowledge Lindus Health’s wider stature as an anti-CRO that is well-equipped to run radically faster and more reliable trials for life science players. Leveraging a commercial model which aligns incentives (fixed-priced quotes per study, with milestone-based payments), the company delivers on its promised value proposition using a combination of one world-class clinical operations team, a unique software platform, as well as its vast Electronic Health Records database. Lindus’ excellence in what it does can be understood once you consider it has, up until now, delivered more than 90 trials across the US, UK, and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia.

“We’ve had the privilege of collaborating with Lindus Health, and their team’s attentiveness and dedication have been beyond our expectations, said Thomas Gurry, CEO and Co-Founder and CEO of Myota, a health tech start-up that aims to improve well-being and prevent chronic diseases.”Their passion is evident in every aspect of their work, from meticulous study planning to execution.”

Must Read

Related News